Sarah A. O’Dowd
DirectoratProtagonist Therapeutics· In proxies 2023–2025
Sarah A. O’Dowd sits on 2 public boards.
Boards1
- Protagonist TherapeuticsDirector · 5 yr on the boardIndependentAudit, Nominating and Corporate Governance—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- Protagonist TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role +1,307%
- Ichor Holdings, Ltd.Public company · 5 yr
- Director2020 – 2025 · 5 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?